Article Listing

FDA News
Dec 2, 2019
On November 21, 2019, the U.S. Food and Drug Administration approved cenobamate (XCOPRI®) for the treatment of focal epilepsy in adults. This medication will be available in the pharmacy by the spring or summer of 2020. XCOPRI was developed by SK...
Scientists in a Lab
Nov 26, 2019
Two publications from the lab of Dr. Wolfgang Löscher, an Epilepsy Foundation grant awardee, present findings about the discovery of a novel mTOR inhibitor called PQR620 and its potential role in treating chronic epilepsy.  Dr. Wolfgang Löscher...
Nov 26, 2019
Online chat on Thursday, December 19, 2019, 8:00 to 9:00 p.m. ET Calling all chatters!  You’re cordially invited to a special Chat About Holiday Party. Please join us on Thursday, December 19, 2019 from 8:00 p.m. to 9:00 p.m. ET, to celebrate the...
Woman listening to music through headphones
Nov 26, 2019
In this article, Emon Chakraborty PhD provides information about the risk factors of autism spectrum disorders (ASD) and epilepsy. The effect of music on the seizure frequency in these conditions is also reviewed. Complex and Co-existing Conditions...
Nov 19, 2019
Webinar on Tuesday, December 17, 2019, at Noon to 1:00 p.m. ET Register Here   Join us for an educational webinar, “Epilepsy and Cognition.” Epilepsy is a chronic neurologic disease that impacts over 3.4 million people in the United States. Over...

Our Mission

The mission of the Epilepsy Foundation is to lead the fight to overcome the challenges of living with epilepsy and to accelerate therapies to stop seizures, find cures, and save lives.

24/7 helpline